Abstract
N-Oxide-containing compounds have been developed as prodrugs that are selectively bioactivated in the hypoxic cells in tumors. This selectivity is based on the net reduction of the N-oxide moiety in the absence of oxygen, in a one or two-electron process, by reductive enzymes. A wide range of N-oxides have been studied and some of them are currently in clinical use. This review covers the principal families of compounds under study and in clinical trials.
Keywords: N-Oxides, Hypoxia, Cytotoxins, Tumor Hypoxia, Bioreductive Agents, Imidazopyridopyrazine N-Oxide and Imidazoquin-oxaline N-Oxide, Quinoxaline N,N-Dioxide, Aminoalkylaminoanthraquinone N-Oxide, Aminoalkylaminoacridine N-Oxide
Mini-Reviews in Medicinal Chemistry
Title: N-Oxides as Hypoxia Selective Cytotoxins
Volume: 1 Issue: 3
Author(s): Hugo Cerecetto and Mercedes Gonzalez
Affiliation:
Keywords: N-Oxides, Hypoxia, Cytotoxins, Tumor Hypoxia, Bioreductive Agents, Imidazopyridopyrazine N-Oxide and Imidazoquin-oxaline N-Oxide, Quinoxaline N,N-Dioxide, Aminoalkylaminoanthraquinone N-Oxide, Aminoalkylaminoacridine N-Oxide
Abstract: N-Oxide-containing compounds have been developed as prodrugs that are selectively bioactivated in the hypoxic cells in tumors. This selectivity is based on the net reduction of the N-oxide moiety in the absence of oxygen, in a one or two-electron process, by reductive enzymes. A wide range of N-oxides have been studied and some of them are currently in clinical use. This review covers the principal families of compounds under study and in clinical trials.
Export Options
About this article
Cite this article as:
Cerecetto Hugo and Gonzalez Mercedes, N-Oxides as Hypoxia Selective Cytotoxins, Mini-Reviews in Medicinal Chemistry 2001; 1 (3) . https://dx.doi.org/10.2174/1389557013406891
DOI https://dx.doi.org/10.2174/1389557013406891 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunohistochemical Expression of Vascular Endothelial Growth Factor (VEGF) and its Possible Role in Tumour Progression During Malignant Transformation of Atrophic Epithelium in Oral Submucous Fibrosis
Current Angiogenesis (Discontinued) Nitric Oxide, Peroxynitrite, Peroxynitrous Acid, Nitroxyl, Nitrogen Dioxide, Nitrous Oxide: Biochemical Mechanisms and Bioaction
Current Bioactive Compounds Recent Advances in Optical Molecular Imaging and its Applications in Targeted Drug Delivery
Current Drug Targets PDE5 Inhibitors in Non-Urological Conditions
Current Pharmaceutical Design The Non-Canonical IκB Kinases IKKε and TBK1 as Potential Targets for the Development of Novel Therapeutic Drugs
Current Molecular Medicine Mitochondria-Targeted Antioxidant Peptide SS31 Protects the Retinas of Diabetic Rats
Current Molecular Medicine Iron Metabolism: A Promising Target for Antibacterial Strategies
Recent Patents on Anti-Infective Drug Discovery Epidemiology of Major Congenital Malformations with Specific Focus on Teratogens
Current Drug Safety Radiolabelled Peptides and Monoclonal Antibodies for Therapy Decision Making in Inflammatory Diseases
Current Pharmaceutical Design Editorial [Hot Topic: Stem Cells (Guest Editor: Anand Srivastava)]
Current Topics in Medicinal Chemistry The Role of Obesity in the Development of Polycystic Ovary Syndrome
Current Pharmaceutical Design Mollusk-Derived Growth Factor and the New Subfamily of Adenosine Deaminase-related Growth Factors
Current Pharmaceutical Design Effects of Diet-Derived Molecules on the Tumor Microenvironment
Current Angiogenesis (Discontinued) Majra Honey Abrogated the Normal and Cancer Cells Proliferation Inhibition by Juniperus procera Extract and Extract/Honey Generated AgNPs
Anti-Cancer Agents in Medicinal Chemistry Subject Index To Volume 6
Current Gene Therapy Recent Advances in Intraocular Drug Delivery Systems
Recent Patents on Drug Delivery & Formulation Biomarkers of Osteoarthritis: A Review of Recent Research Progress on Soluble Biochemical Markers, Published Patents and Areas for Future Development
Recent Patents on Biomarkers RAS/Effector Interactions from Structural and Biophysical Perspective
Mini-Reviews in Medicinal Chemistry Cytomegalovirus Infections in Non-Immunocompromised and Immunocompromised Patients in the Intensive Care Unit
Infectious Disorders - Drug Targets Cerenkov Luminescence Imaging at a Glance
Current Molecular Imaging (Discontinued)